Septerna Inc
For the period ended Sep 30, 2024. Filed Nov 20, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 20, 2024
SEPN$52.34+3.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Convertible Preferred Stock and Stockholders’ Deficit
| Convertible Preferred Stock · Additional · AccumulatedOther · Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Series A · Series B · Common Stock · Paid-In · Comprehensive · Accumulated · Stockholders' | ||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Capital | (Loss) Income | Deficit | Deficit | |
| Balance at December 31, 2023 | 75,000,000 | $74,694 | 60,828,720 | $74,521 | 3,168,134 | $3 | $8,199 | $— | $(46,576) | $(38,374) |
| Issuance of common stock upon exercise of stock options | — | — | — | — | 217 | — | 1 | — | — | 1 |
| Vesting of restricted common stock | — | — | — | — | — | — | 6 | — | — | 6 |
| Repurchase of unvested restricted common stock | — | — | — | — | (11,517) | — | — | — | — | — |
| Stock-based compensation expense | — | — | — | — | — | — | 577 | — | — | 577 |
| Net unrealized loss on available-for-sale marketable securities | — | — | — | — | — | — | — | (7) | — | (7) |
| Net loss | — | — | — | — | — | — | — | — | (14,097) | (14,097) |
| Balance at March 31, 2024 | 75,000,000 | $74,694 | 60,828,720 | $74,521 | 3,156,834 | $3 | $8,783 | $(7) | $(60,673) | $(51,894) |
| Issuance of Series B Convertible Preferred Stock, net of issuance costs of $58 | — | — | 60,828,732 | 74,942 | — | — | — | — | — | — |
| Issuance of common stock upon exercise of stock options | — | — | — | — | 6,186 | — | 10 | — | — | 10 |
| Vesting of restricted common stock | — | — | — | — | — | — | 4 | — | — | 4 |
| Stock-based compensation expense | — | — | — | — | — | — | 628 | — | — | 628 |
| Net unrealized loss on available-for-sale marketable securities | — | — | — | — | — | — | — | (1) | — | (1) |
| Net loss | — | — | — | — | — | — | — | — | (16,510) | (16,510) |
| Balance at June 30, 2024 | 75,000,000 | $74,694 | 121,657,452 | $149,463 | 3,163,020 | $3 | $9,425 | $(8) | $(77,183) | $(67,763) |
| Issuance of common stock upon exercise of stock options | — | — | — | — | 2,730 | — | 5 | — | — | 5 |
| Vesting of restricted common stock | — | — | — | — | — | — | 6 | — | — | 6 |
| Repurchase of unvested restricted common stock | — | — | — | — | (2,782) | — | — | — | — | — |
| Stock-based compensation expense | — | — | — | — | — | — | 683 | — | — | 683 |
| Net unrealized gain on available-for-sale marketable securities | — | — | — | — | — | — | — | 184 | — | 184 |
| Net loss | — | — | — | — | — | — | — | — | (20,523) | (20,523) |
| Balance at September 30, 2024 | 75,000,000 | $74,694 | 121,657,452 | $149,463 | 3,162,968 | $3 | $10,119 | $176 | $(97,706) | $(87,408) |
Condensed Statements of Convertible Preferred Stock and Stockholders’ Deficit
| Convertible Preferred Stock · Additional · AccumulatedOther · Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Series A · Series B · Common Stock · Paid-In · Comprehensive · Accumulated · Stockholders' | ||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Capital | (Loss) Income | Deficit | Deficit | |
| Balance at December 31, 2022 | 75,000,000 | $74,694 | — | $— | 3,181,829 | $3 | $6,552 | $— | $(50,756) | $(44,201) |
| Vesting of restricted common stock | — | — | — | — | — | — | 6 | — | — | 6 |
| Stock-based compensation expense | — | — | — | — | — | — | 343 | — | — | 343 |
| Net loss | — | — | — | — | — | — | — | — | (9,171) | (9,171) |
| Balance at March 31, 2023 | 75,000,000 | 74,694 | — | — | 3,181,829 | 3 | 6,901 | — | (59,927) | (53,023) |
| Issuance of Series B Convertible Preferred Stock, net of issuance costs of $479 | — | — | 58,801,098 | 72,021 | — | — | — | — | — | — |
| Vesting of restricted common stock | — | — | — | — | — | — | 9 | — | — | 9 |
| Repurchase of unvested restricted common stock | — | — | — | — | (2,807) | — | — | — | — | — |
| Stock-based compensation expense | — | — | — | — | — | — | 355 | — | — | 355 |
| Net loss | — | — | — | — | — | — | — | — | (10,598) | (10,598) |
| Balance at June 30, 2023 | 75,000,000 | 74,694 | 58,801,098 | 72,021 | 3,179,022 | 3 | 7,265 | — | (70,525) | (63,257) |
| Issuance of Series B Convertible Preferred Stock, net of issuance costs of $0 | — | — | 2,027,622 | 2,500 | — | — | — | — | — | — |
| Vesting of restricted common stock | — | — | — | — | — | — | 6 | — | — | 6 |
| Repurchase of unvested restricted common stock | — | — | — | — | (10,888) | — | — | — | — | — |
| Stock-based compensation expense | — | — | — | — | — | — | 347 | — | — | 347 |
| Net loss | — | — | — | — | — | — | — | — | (10,945) | (10,945) |
| Balance at September 30, 2023 | 75,000,000 | $74,694 | 60,828,720 | $74,521 | 3,168,134 | $3 | $7,618 | $— | $(81,470) | $(73,849) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.